Mintz advised Asimov on the deal.Asimov announced its $200 million fundraising aimed to scale the company’s tools and services business in biologics, cell/gene therapies, and RNA. Boston-based…
Asimov’s $200 Million Fundraising


Mintz advised Asimov on the deal.Asimov announced its $200 million fundraising aimed to scale the company’s tools and services business in biologics, cell/gene therapies, and RNA. Boston-based…
…